US EditionNUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Nutex Health reported a 214% revenue increase and $21.2 million net income in Q1 2025, driven by arbitration payments and a $25 million stock buyback, boosting investor confidence.
- After‑hours, Nutex Health Inc. shares surged on Tuesday following the release of restated Q1 2025 results, with the stock rising to $21200K.
- The restated results show total revenue of $211.8 million for Q1 2025, up 214.0%, and net income of $21.2 million versus a $0.4 million loss, according to the Company.
- The company disclosed EBITDA rose to $51.5 million for Q1 2025 from $7.1 million, stock-based compensation was $27.6 million mostly one-time, and IDR arbitration improved insurer payments.
- The Board of Directors authorized a $25 million stock buyback, and the stock surged 253.02% over the past year, reflecting strong momentum.
- The company says the restatement involved non‑cash reclassifications, including a $20.7 million reclassification, with no material effect on liquidity or adjusted EBITDA.
35 Articles
35 Articles
The Norfolk Daily News
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5%Net income attributable to Nutex Health Inc. of $3.5 million for the first half of 2025 versus…
Why Did Nutex Health's (NUTX) Shares Soar 21% After Hours? - Nutex Health (NASDAQ:NUTX)
Nutex Health Inc. (NASDAQ:NUTX) shares jumped 20.97% in after-hours trading on Tuesday, reaching $120. Check out the current price of NUTX stock here. The stock closed Tuesday's regular session down 4.57% at $99.20, according to Benzinga Pro data. Q2 2025 Results Drive Rally The physician-led healthcare company reported second-quarter and year-to-date financial results. Period 2025 Revenue (USD million) 2024 Revenue (USD million) YoY Change (%…
Nutex Health (NASDAQ:NUTX) Issues Earnings Results, Beats Expectations By $2.48 EPS
Nutex Health (NASDAQ:NUTX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($2.95) EPS for the quarter, beating the consensus estimate of ($5.43) by $2.48, Zacks reports. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%. Nutex Health Trading Down 4.6% Shares of NASDAQ:NUTX […]
Coverage Details
Bias Distribution
- 93% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
